Main Article Content
Abstract
In current scenario, the number of infectious disease such as HIV, TB etc. has tremendously increases. It was also observed that continuous use of first line therapy against these infectious cases leads to resistance. Here, in the present work, we deals with designs, synthesis and evaluation of anti tuberculosis compounds along with their biological activities. This will help the reader in successful designing of new drugs against different strains of mycobacterium tuberculosis.